BCR and lymphoma: Because expression of IgM (immunoglobulin M) is a hallmark of B cells and most lymphoma cell lines contain IgM as immunoglobulin part of the BCR [21], [23] anti-IgM antibodies are generally used for activation of the BCR in-vitro[3], [24]–[27].